Pharmaceutical Acquisitions

Pharmaceutical Companies Made Acquisitions a Top Priority in 2019

by Kyle Murphy, PhD

By the midway point of 2019, more than $200 billion had exchanged hands, exceeding previous years of $198 billion and $178 in 2018 and 2017, respectively. And the recent closing of Bristol-Myers Squibb...